1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Medical Case Management Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Medical Case Management Market, by Mode of Services
8.1.1 Web-Based Case Management
8.1.1.1. Market Revenue and Forecast
8.1.2. Telephonic Case Management
8.1.2.1. Market Revenue and Forecast
8.1.3. Filed Case Management
8.1.3.1. Market Revenue and Forecast
8.1.4. Bilingual Case Management
8.1.4.1. Market Revenue and Forecast
9.1. Medical Case Management Market, by Severity of Case
9.1.1. Catastrophic Case
9.1.1.1. Market Revenue and Forecast
9.1.2. Chronic Pain
9.1.2.1. Market Revenue and Forecast
9.1.3. Independent Medical Examination
9.1.3.1. Market Revenue and Forecast
9.1.4. Long-term Disability
9.1.4.1. Market Revenue and Forecast
9.1.5. Short-Term Disability
9.1.5.1. Market Revenue and Forecast
10.1. Medical Case Management Market, by End-User
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast
10.1.2. Home Care Settings
10.1.2.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Mode of Services
11.1.2. Market Revenue and Forecast, by Severity of Case
11.1.3. Market Revenue and Forecast, by End-User
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Mode of Services
11.1.4.2. Market Revenue and Forecast, by Severity of Case
11.1.4.3. Market Revenue and Forecast, by End-User
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Mode of Services
11.1.5.2. Market Revenue and Forecast, by Severity of Case
11.1.5.3. Market Revenue and Forecast, by End-User
11.2. Europe
11.2.1. Market Revenue and Forecast, by Mode of Services
11.2.2. Market Revenue and Forecast, by Severity of Case
11.2.3. Market Revenue and Forecast, by End-User
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Mode of Services
11.2.4.2. Market Revenue and Forecast, by Severity of Case
11.2.4.3. Market Revenue and Forecast, by End-User
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Mode of Services
11.2.5.2. Market Revenue and Forecast, by Severity of Case
11.2.5.3. Market Revenue and Forecast, by End-User
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Mode of Services
11.2.6.2. Market Revenue and Forecast, by Severity of Case
11.2.6.3. Market Revenue and Forecast, by End-User
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Mode of Services
11.2.7.2. Market Revenue and Forecast, by Severity of Case
11.2.7.3. Market Revenue and Forecast, by End-User
11.3. APAC
11.3.1. Market Revenue and Forecast, by Mode of Services
11.3.2. Market Revenue and Forecast, by Severity of Case
11.3.3. Market Revenue and Forecast, by End-User
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Mode of Services
11.3.4.2. Market Revenue and Forecast, by Severity of Case
11.3.4.3. Market Revenue and Forecast, by End-User
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Mode of Services
11.3.5.2. Market Revenue and Forecast, by Severity of Case
11.3.5.3. Market Revenue and Forecast, by End-User
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Mode of Services
11.3.6.2. Market Revenue and Forecast, by Severity of Case
11.3.6.3. Market Revenue and Forecast, by End-User
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Mode of Services
11.3.7.2. Market Revenue and Forecast, by Severity of Case
11.3.7.3. Market Revenue and Forecast, by End-User
11.4. MEA
11.4.1. Market Revenue and Forecast, by Mode of Services
11.4.2. Market Revenue and Forecast, by Severity of Case
11.4.3. Market Revenue and Forecast, by End-User
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Mode of Services
11.4.4.2. Market Revenue and Forecast, by Severity of Case
11.4.4.3. Market Revenue and Forecast, by End-User
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Mode of Services
11.4.5.2. Market Revenue and Forecast, by Severity of Case
11.4.5.3. Market Revenue and Forecast, by End-User
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Mode of Services
11.4.6.2. Market Revenue and Forecast, by Severity of Case
11.4.6.3. Market Revenue and Forecast, by End-User
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Mode of Services
11.4.7.2. Market Revenue and Forecast, by Severity of Case
11.4.7.3. Market Revenue and Forecast, by End-User
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Mode of Services
11.5.2. Market Revenue and Forecast, by Severity of Case
11.5.3. Market Revenue and Forecast, by End-User
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Mode of Services
11.5.4.2. Market Revenue and Forecast, by Severity of Case
11.5.4.3. Market Revenue and Forecast, by End-User
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Mode of Services
11.5.5.2. Market Revenue and Forecast, by Severity of Case
11.5.5.3. Market Revenue and Forecast, by End-User
12.1. EK Health Services Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. EagleOne Case Management
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. MMRO INC
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Genex Services, LLC
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. GMMI, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. TRIUNE Health Group
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. PayerFusion Holdings LLC
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Sierra Nevada Administrators
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. AXIOM MEDICAL CONSULTING, LLC
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Medical Case Management Group
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client